Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study
Authors
Keywords
Bladder cancer, Urinary biomarkers, Urinary cytology, Recurrence, Progression
Journal
WORLD JOURNAL OF UROLOGY
Volume 34, Issue 10, Pages 1405-1409
Publisher
Springer Nature
Online
2016-02-24
DOI
10.1007/s00345-016-1795-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
- (2016) Ashish M. Kamat et al. EUROPEAN UROLOGY
- NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
- (2016) Paul Lau et al. CUAJ-Canadian Urological Association Journal
- Biomarkers for detection and surveillance of bladder cancer
- (2016) Lorne I. Budman et al. CUAJ-Canadian Urological Association Journal
- Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
- (2015) Tilman Todenhöfer et al. BMC CANCER
- Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
- (2015) Faysal A. Yafi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer-institutional experience and review
- (2014) Binnur Önal et al. DIAGNOSTIC CYTOPATHOLOGY
- Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer
- (2013) Faysal A. Yafi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Overestimation of Nuclear Matrix Protein 22 in Concentrated Urine
- (2013) Jae Young Joung et al. UROLOGY
- Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravescal therapy
- (2012) Wassim Kassouf et al. CUAJ-Canadian Urological Association Journal
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
- (2012) Ashish M. Kamat et al. JOURNAL OF UROLOGY
- Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder Cancer
- (2012) Tilman Todenhöfer et al. UROLOGY
- Influencing factors on the NMP-22 urine assay: an experimental model
- (2012) Makito Miyake et al. BMC Urology
- Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology
- (2011) Shahrokh F. Shariat et al. CANCER
- Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma
- (2011) Tilman Todenhöfer et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Accuracy of Urine Cytology and the Significance of an Atypical Category
- (2009) Fadi Brimo et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now